Trial Search Results

Prevention of Persistent Opioid Use in Mothers

Our previous work has identified the group of women at risk for prolonged pain, opioid use and poor functional recovery after childbirth. The optimal intervention to mitigate this risk is unknown. We propose to test an analgesic adjutant that is commonly used for post-operative pain compared to placebo to improve post-partum recovery.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Drug: Gabapentin
  • Drug: Placebo


Phase 4


Inclusion Criteria:

   - Delivery within 5 days, able to provide informed consent, English speaker

Exclusion Criteria:

   - Opiate use disorder

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Pamela Flood, MD, MA
Not Recruiting